Zevra Therapeutics (ZVRA) Interest Coverage Ratio (2014 - 2026)

Zevra Therapeutics has reported Interest Coverage Ratio for 13 years, with the latest figure at 30.48 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio rose 1219.15% year-over-year to 30.48; the trailing twelve-month figure through Mar 2026 stood at 0.7 (up 91.59% YoY), and the FY2025 full-year result was 7.89, up 33.33% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 30.48, up from 4.78 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 30.48 in Q1 2026, with the low at 70.5 in Q1 2023.
• Historically, Interest Coverage Ratio has averaged 17.92 across 5 years, with a median of 15.93 in 2023.
• Annual changes were most pronounced in 2025 — Interest Coverage Ratio tumbled 213.55% — and 2026, when it surged 1219.15%.
• Zevra Therapeutics' Interest Coverage Ratio stood at 27.8 in 2022, then increased by 27.88% to 20.05 in 2023, then surged by 64.95% to 7.03 in 2024, then jumped by 168.05% to 4.78 in 2025, then soared by 537.35% to 30.48 in 2026.
• The last three Interest Coverage Ratio figures came in at 30.48 (Q1 2026), 4.78 (Q4 2025), and 2.02 (Q3 2025), per Business Quant data.